Drukarch_1987_Eur.J.Pharmacol_141_153

Reference

Title : 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current - Drukarch_1987_Eur.J.Pharmacol_141_153
Author(s) : Drukarch B , Kits KS , Van der Meer EG , Lodder JC , Stoof JC
Ref : European Journal of Pharmacology , 141 :153 , 1987
Abstract :

The in vitro release of acetylcholine in rat brain tissue was inhibited by 9-amino-1,2,3,4-tetrahydroacridine (THA). Atropine antagonized this effect of THA. As THA does not display an affinity for muscarinic receptors, we conclude that THA inhibits acetylcholinesterase activity. In electrophysiological studies with neurons of Lymnaea stagnalis, THA inhibited the slow outward K+ current and consequently increased the duration of the action potentials. It is discussed that both effects of THA possibly contribute to its reported effect in the treatment of patients with Alzheimer's disease.

PubMedSearch : Drukarch_1987_Eur.J.Pharmacol_141_153
PubMedID: 2444444

Related information

Citations formats

Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC (1987)
9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current
European Journal of Pharmacology 141 :153

Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC (1987)
European Journal of Pharmacology 141 :153